Literature DB >> 30104696

Economic comments on proposal for a novel cancer drug pricing model.

Mark J C Nuijten1,2, Jan Vis3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30104696     DOI： 10.1038/s41571-018-0083-2

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  3 in total

1.  An integrated valuation model for payer and investor.

Authors:  Mark Nuijten; Stefano Capri
Journal:  J Mark Access Health Policy       Date:  2022-05-29

2.  The impact of early phase price agreements on prices of orphan drugs.

Authors:  Mark Nuijten; Philippe Van Wilder
Journal:  BMC Health Serv Res       Date:  2021-03-12       Impact factor: 2.655

3.  Pricing Zolgensma - the world's most expensive drug.

Authors:  Mark Nuijten
Journal:  J Mark Access Health Policy       Date:  2021-12-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.